180 related articles for article (PubMed ID: 18647248)
1. Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available.
Ara R; Brazier J
Value Health; 2009; 12(2):346-53. PubMed ID: 18647248
[TBL] [Abstract][Full Text] [Related]
2. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
3. Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available).
Ara R; Brazier J
Value Health; 2008 Dec; 11(7):1131-43. PubMed ID: 18489495
[TBL] [Abstract][Full Text] [Related]
4. Predicting preference-based SF-6D index scores from the SF-8 health survey.
Wang P; Fu AZ; Wee HL; Lee J; Tai ES; Thumboo J; Luo N
Qual Life Res; 2013 Sep; 22(7):1675-83. PubMed ID: 23054496
[TBL] [Abstract][Full Text] [Related]
5. Mapping utility scores from a disease-specific quality-of-life measure in bariatric surgery patients.
Sauerland S; Weiner S; Dolezalova K; Angrisani L; Noguera CM; García-Caballero M; Rupprecht F; Immenroth M
Value Health; 2009; 12(2):364-70. PubMed ID: 20667063
[TBL] [Abstract][Full Text] [Related]
6. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
Wong CK; Lam CL; Wan YF; Rowen D
Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
[TBL] [Abstract][Full Text] [Related]
7. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
8. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
[TBL] [Abstract][Full Text] [Related]
9. Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis.
Bansback N; Marra C; Tsuchiya A; Anis A; Guh D; Hammond T; Brazier J
Arthritis Rheum; 2007 Aug; 57(6):963-71. PubMed ID: 17665482
[TBL] [Abstract][Full Text] [Related]
10. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index.
O'Brien BJ; Spath M; Blackhouse G; Severens JL; Dorian P; Brazier J
Health Econ; 2003 Nov; 12(11):975-81. PubMed ID: 14601159
[TBL] [Abstract][Full Text] [Related]
11. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
12. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
[TBL] [Abstract][Full Text] [Related]
13. Predicting SF-6D utility scores from the neck disability index and numeric rating scales for neck and arm pain.
Carreon LY; Anderson PA; McDonough CM; Djurasovic M; Glassman SD
Spine (Phila Pa 1976); 2011 Mar; 36(6):490-4. PubMed ID: 20847713
[TBL] [Abstract][Full Text] [Related]
14. Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 preference-based SF-6D in chronic kidney disease.
Davison SN; Jhangri GS; Feeny DH
Value Health; 2009; 12(2):340-5. PubMed ID: 18657096
[TBL] [Abstract][Full Text] [Related]
15. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
[TBL] [Abstract][Full Text] [Related]
16. Predicting SF-6D utility scores from the Oswestry disability index and numeric rating scales for back and leg pain.
Carreon LY; Glassman SD; McDonough CM; Rampersaud R; Berven S; Shainline M
Spine (Phila Pa 1976); 2009 Sep; 34(19):2085-9. PubMed ID: 19730215
[TBL] [Abstract][Full Text] [Related]
17. Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients.
Wong CK; Lam ET; Lam CL
Qual Life Res; 2013 Dec; 22(10):2973-81. PubMed ID: 23564621
[TBL] [Abstract][Full Text] [Related]
18. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D.
Brazier JE; Kolotkin RL; Crosby RD; Williams GR
Value Health; 2004; 7(4):490-8. PubMed ID: 15449641
[TBL] [Abstract][Full Text] [Related]
19. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
Richardson SS; Berven S
Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
[TBL] [Abstract][Full Text] [Related]
20. Estimating the SF-6D value set for a population-based sample of Brazilians.
Cruz LN; Camey SA; Hoffmann JF; Rowen D; Brazier JE; Fleck MP; Polanczyk CA
Value Health; 2011; 14(5 Suppl 1):S108-14. PubMed ID: 21839880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
